LONDON (Reuters) – A single dose of the Pfizer COVID-19 vaccine developed in partnership with BioNTech could significantly reduce the risk of transmission after a single dose, results of a UK study found on Friday.
Researchers analysed results from thousands of COVID-19 tests carried out each week as part of hospital screenings of healthcare staff in Cambridge, eastern England.
(Reporting by Kate Kelland; Editing by David Goodman)
